GMP Warning Letter Downward Trend Accelerates; Few Oral Solids Get Cited
Executive Summary
The number of warning letters issued by FDA to pharmaceutical firms for good manufacturing practices fell by half in fiscal 2003
You may also be interested in...
GMP Warning Letter Use Remains Low In FY 2004
FDA's conservative approach to the use of warning letters to support its GMP enforcement strategy continued from fiscal year 2003 into 2004
GMP Warning Letter Use Remains Low In FY 2004
FDA's conservative approach to the use of warning letters to support its GMP enforcement strategy continued from fiscal year 2003 into 2004
Warning Letter “Templates” Likely Part Of GMP Proposal In August
The Center for Drug Evaluation & Research is likely to propose warning letter "templates" as part of its revisions to the Good Manufacturing Practices regulations coming out in August